Loading
Life sciences · Journal article
Archives of Rheumatology · October 14, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Journal article.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Background/Aims: To map global research on osteoarthritis (OA) and metabolic diseases, separately examining individual metabolic diseases and metabolic syndrome (MetS), and identify gaps and emerging frontiers. Materials and Methods: Web of Science Core Collection publications (2009–2025) were retrieved on February 22, 2026. Co-authorship and keyword co-occurrence networks, Louvain clustering (modularity and silhouette evaluation), burst detection, and keyword-cluster visualization were performed. Betweenness centrality assessed country collaboration. Chord diagrams and temporal streamgraphs mapped pairwise disease co-study patterns and trajectories. GLP-1 receptor agonist (GLP-1RA) trends were assessed using 24 predefined terms. Results: We included 10,217 articles from 1582 journals by 38,665 authors. Annual output rose 4.4-fold between 2009 and 2025. The United States (33.4%), China (15.0%), and the United Kingdom (9.3%) were the leading contributors. Ten major themes were identified: progression, arthroplasty, physical activity, inflammation, prevalence, Mendelian randomization, meta-analysis, knee OA, body mass index, and hip. Obesity and type 2 diabetes were the most frequently co-studied conditions. Obesity showed the strongest sustained growth, whereas nonalcoholic fatty liver disease (NAFLD) received limited attention. Inflammation and risk were the strongest burst terms. OA-related GLP-1RA publications increased 9.7-fold after 2021. Conclusion: OA-metabolic disease research is expanding rapidly. NAFLD, hyperuricemia, and MetS remain underexplored, while GLP-1RA is a major emerging frontier. Cite this article as: Weng Y, Wu J, Xie S, Zhang Y. Relationship Between Osteoarthritis and Metabolic Diseases: A Bibliometric and Visual Analysis. ArchRheumatol. Published online October 14, 2026. doi: 10.5152/ ArchRheumatol.2026.26556.